SIXTH INTERNATIONAL CONFERENCE ON CHRONOPHARMACOLOGY
SIXTH INTERNATIONAL CONFERENCE ON CHRONOPHARMACOLOGY
批准号:
2105063
负责人:
ERHARD HAUS
金额:
$1.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-05-16 至 1995-04-30
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The Sixth International Conference on Chronopharmacology will be held in
Amelia Island, Florida, from July 6 to July 9, 1994. The Conference will
summarize the current knowledge on time dependent rhythmic changes in
pharmacokinetics and pharmacodynamics which occur as a function of
biologic rhythms of different frequencies and will discuss their
implications for drug development, drug testing, and medical practice.
The Conference will consist of five symposia with presentations by invited
speakers. The topics will be: "The Design of Chronopharmacologic
Studies", "Chronopharmacology in Drug Development", "Chronopharmacology in
Neuropsychiatry", "Rhythms as Biomarkers", and "Biologic Rhythm in
Clinical Practice". each symposium will be supplemented by a workshop on
the same topic. New peer reviewed material will be presented in sessions
on "Cardiovascular Chronopharmacology" (3), the "Chronopharmacology of
Cancer" (2), "Gastrointestinal Chronopharmacology", "Pulmonary
Chronopharmacology," Chronopharmacology of Pain" (1 each) and four
sessions on general chronopharmacology. These sessions will also be
supplemented by luncheon or evening workshops. It is the aim of this
Conference to bring the new developments in the field of
chronopharmacology and chronotherapeutics and the methodology necessary
for their application to the attention of healthcare workers at all levels
and of pharmaceutical scientists involved in drug development and drug
testing, and in turn receive their input for further development of
chronotherapeutic treatment regimen. The introduction of
chronopharmacologic methods is expected to optimize drug development and
drug testing by introducing techniques which take into account the
biologic variations in pharmacokinetics and pharmacodynamics in the
experimental animals and/or human subjects to be treated. In drug
development and drug testing, the choosing of the "right" time will
greatly improve the accuracy and precision of the results obtained and
avoid misleading results and potential damage to patients. In its
application to patients, this approach aims at treating patients at a time
(circadian or other) when the desired effects are maximal and the
undesirable side-effects minimized. Increased precision in drug testing
and improved treatment results with medications given at the time when
needed and optimally effective will lead to a decrease in cost of drug
testing and of medical care.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文